Assoc. Prof. Dr. cetin bayrak | Organic Chemistry | Best Researcher Award

Assoc. Prof. Dr. cetin bayrak | Organic Chemistry | Best Researcher Award

Assoc. Prof. Dr. cetin bayrak , Agri Ibrahim Cecen University , Turkey

Dr. Çetin Bayrak is an Associate Professor at Ağrı İbrahim Çeçen University, Turkey. With a strong academic foundation in organic chemistry, he holds dual Bachelor’s degrees in Chemistry and Food Engineering from Atatürk University, where he also completed his MSc and PhD in Organic Chemistry. Dr. Bayrak’s research spans natural product synthesis, bromination, and mechanistic organic chemistry, focusing on biologically active molecules and enzyme inhibition studies. He has published extensively in top-tier journals and contributed to several high-impact research projects funded by TUBITAK. Dr. Bayrak has also been a visiting scholar with the Kozlowski Group, furthering his expertise in synthesis and catalysis. In addition to his academic accomplishments, he has presented at numerous international conferences, showcasing his innovative research. An expert in NMR spectroscopy and organic compound characterization, Dr. Bayrak’s work bridges fundamental organic chemistry and applied biological research.

Professional Profile

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Çetin Bayrak is a distinguished academic and researcher with extensive contributions to the field of organic chemistry. He has demonstrated excellence in education, holding dual bachelor’s degrees in Chemistry and Food Engineering, and advanced degrees (M.Sc. and Ph.D.) from Atatürk University. His research career includes notable positions, such as Associate Professor and Assistant Professor at Ağrı İbrahim Çeçen University, and a visiting scholar experience that highlights his global scientific engagement. Dr. Çetin Bayrak is a highly suitable candidate for the “Best Researcher Awards” due to his significant academic achievements, impactful research contributions, and demonstrated commitment to advancing the field of organic chemistry. His innovative work and dedication make him a strong contender for this prestigious recognition.

🎓Education:

Dr. Çetin Bayrak completed his education at Atatürk University, Erzurum, Turkey. He earned a BSc in Chemistry (2004–2008) and a double major in Food Engineering (2005–2009). For postgraduate studies, he pursued an MSc in Organic Chemistry (2010–2013) and a PhD in Organic Chemistry (2013–2017). His research during this time laid a robust foundation in organic synthesis, with a focus on biologically active bromophenols and reaction mechanisms. His academic journey continued as an Assistant Professor at Ağrı İbrahim Çeçen University (2017–2024) and later as an Associate Professor (2024–present). From 2021 to 2023, Dr. Bayrak was a visiting scholar with the Kozlowski Group, where he advanced his expertise in triazole phosphines and catalytic applications. This diverse and rigorous academic training has shaped him into a leading researcher in organic and mechanistic chemistry, emphasizing biologically significant compound synthesis and enzyme activity studies.

🏢Work Experience:

Dr. Çetin Bayrak has a rich professional background in organic chemistry research and teaching. He began his academic career as an Assistant Professor at Ağrı İbrahim Çeçen University in 2017, where he was promoted to Associate Professor in 2024. From 2021 to 2023, he worked as a visiting scholar with the Kozlowski Group, focusing on triazole phosphines and catalytic applications. His extensive project experience includes significant contributions to TUBITAK-funded research, such as the first synthesis of biologically active bromophenols (Project 113Z702) and the total synthesis of Onosmon analogs (Project 119R034). Dr. Bayrak has presented his work at numerous national and international conferences, sharing insights into enzyme inhibition, molecular docking, and natural product synthesis. He is proficient in advanced characterization techniques like NMR, GCMS, and HPLC, showcasing a commitment to cutting-edge research in mechanistic and applied organic chemistry.

🏅Awards: 

Dr. Çetin Bayrak has received recognition for his groundbreaking contributions to organic chemistry. He was honored with funding through prestigious TUBITAK programs, including Project 2219 for his work on triazole phosphines and their catalytic applications (2021–2023). His projects, such as the first synthesis of biologically active bromophenols and the total synthesis of Onosmon analogs, highlight his innovative approach to natural product synthesis and catalysis. Dr. Bayrak’s consistent publication of high-impact research has earned him accolades within the scientific community, and his presentations at esteemed international conferences have further distinguished his academic career. These honors underscore his dedication to advancing the field of organic chemistry, with a particular focus on biologically significant compounds and their applications.

🔬Research Focus:

Dr. Çetin Bayrak’s research centers on organic synthesis, focusing on the development of biologically active molecules and natural product derivatives. His work includes bromination reactions, mechanistic organic chemistry, and enzyme inhibition studies. Dr. Çetin Bayrak has synthesized novel bromophenol compounds, characterized their biological activities, and explored their inhibitory effects on enzymes like carbonic anhydrase and aldose reductase. He is also proficient in molecular docking studies, elucidating enzyme-ligand interactions. Recent projects include developing triazole phosphines for selective oxidative addition and investigating their catalytic properties. With expertise in advanced analytical techniques like NMR and HPLC, Dr. Çetin Bayrak’s research contributes significantly to medicinal chemistry and material science, bridging theoretical and applied organic chemistry.

Publication Top Notes:

Title: The first synthesis, carbonic anhydrase inhibition, and anticholinergic activities of some bromophenol derivatives with S including natural products
Authors: C. Bayrak, P. Taslimi, H.S. Karaman, İ. Gülçin, A. Menzek
Citations: 139
Year: 2019

Title: The first synthesis of 4-phenylbutenone derivative bromophenols including natural products and their inhibition profiles for carbonic anhydrase, acetylcholinesterase, and…
Authors: Ç. Bayrak, P. Taslimi, İ. Gülçin, A. Menzek
Citations: 135
Year: 2017

Title: The first synthesis and antioxidant and anticholinergic activities of 1-(4, 5-dihydroxybenzyl)pyrrolidin-2-one derivative bromophenols including natural products
Authors: M. Rezai, C. Bayrak, P. Taslimi, İ. Gülçin, A. Menzek
Citations: 87
Year: 2018

Title: Synthesis and rearrangement reactions of 1,4-dihydrospiro[1,4-methanonaphthalene-9,1′-cyclopropane] derivatives
Authors: C. Bayrak, H. Senol, S. Sirtbasi, E. Sahin, A. Menzek
Citations: 19
Year: 2018

Title: Cycloaddition reaction of spiro[2.4]hepta-4,6-dien-1-ylmethanol and PTAD: a new rearrangement
Authors: H. Şenol, C. Bayrak, A. Menzek, E. Şahin, M. Karakuş
Citations: 18
Year: 2016

Title: Synthesis and photophysical properties of new pyrazolines with triphenyl and ester derivatives
Authors: A.M. Şenol, Ç. Bayrak, A. Menzek, Y. Onganer, N. Yaka
Citations: 14
Year: 2020

Title: Synthesis and aldose reductase inhibition effects of celecoxib derivatives containing pyrazole linked-sulfonamide moiety
Authors: C. Bayrak
Citations: 10
Year: 2022

Title: The first synthesis of phenylpropanoid derivative bromophenols including natural products: Formation of an indene derivative compound
Authors: C. Bayrak, A. Menzek
Citations: 8
Year: 2020

Title: 1,3‐dipolar cycloaddition reactions of the compound obtained from cyclopentadiene‐PTAD and biological activities of adducts formed selectively
Authors: M.A. Yavari, P. Taslimi, C. Bayrak, T. Taskin‐Tok, A. Menzek
Citations: 7
Year: 2022

Title: Synthesis and biological activity of some bromophenols and their derivatives including natural products
Authors: C. Bayrak, P. Taslimi, N. Kilinc, I. Gulcin, A. Menzek
Citations: 6
Year: 2023

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Dr. Hongjian Qin , Shanghai Institute of Materia Medica, CAS , China

Dr. Hongjian Qin is an accomplished researcher in sustainable and green chemistry, with expertise in drug process development and medicinal administration. He earned his Ph.D. in Organic Chemistry from the Chinese Academy of Sciences, being recognized as an Excellent Graduate in 2024. Dr. Hongjian Qin’s contributions to the field span over three years, emphasizing environmentally friendly pharmaceutical synthesis and active pharmaceutical ingredient (API) development. Currently serving as Research Director at Topharman Company Limited, he continues to advance innovative solutions in drug development. His work includes mentoring students, enhancing resource recovery, and participating in COVID-19 research. With numerous impactful publications, Dr. Hongjian Qin is a dedicated professional committed to promoting sustainability and advancing solutions for global environmental challenges.

Professional Profile:

Scopus 

Summary of Suitability for Award:

Dr. Hongjian Qin is an exemplary candidate for the “Best Researcher Awards,” with a distinguished career in sustainable and green chemistry. His pioneering research in eco-friendly pharmaceutical synthesis has significantly contributed to reducing industrial waste and enhancing process efficiency, aligning with global sustainability objectives. Dr. Hongjian Qin’s innovative work on ligand-free catalysis, large-scale API production, and impurity profiling reflects his expertise in developing practical solutions for complex challenges in organic chemistry and medicinal chemistry. Dr. Hongjian Qin’s research excellence, innovative contributions, and global impact make him a highly deserving candidate for the “Best Researcher Awards.” His work not only addresses critical scientific challenges but also fosters sustainable practices in drug development, making a lasting impact on both academia and industry.

🎓Education:

Dr. Hongjian Qin holds a Ph.D. in Organic Chemistry from the Chinese Academy of Sciences , specializing in process development of drug substances and medicinal administration. His doctoral work was conducted at the Key Laboratory of Plant Resources and Chemistry in Arid Regions, showcasing expertise in sustainable pharmaceutical synthesis. He completed a Master of Engineering in Organic Chemistry from Guangxi University, focusing on the process development of drug substances. Dr. Qin’s academic journey began with a Bachelor of Science in Organic Chemistry from Guangxi University . His educational foundation combines rigorous theoretical knowledge with practical applications, preparing him to address complex challenges in green and sustainable chemistry.

🏢Work Experience:

Dr. Hongjian Qin’s professional journey spans over a decade, focusing on pharmaceutical synthesis and sustainable chemistry. As Research Director at Topharman Company Limited (2024–present), he spearheads innovations in active pharmaceutical ingredients (APIs) and emphasizes good manufacturing practices (GMP). Previously, as a Research Assistant at the Shanghai Institute of Materia Medica (2021–2024), he supported COVID-19 research projects, trained students, and enhanced pharmaceutical waste recovery techniques. At the Xinjiang Engineering Research Centre for Key Technologies and Processes of Ethnomedicine (2015–2021), Dr. Hongjian Qin led projects on sustainable API production and industrial resource recovery. His experiences reflect a blend of academic research and industrial application, driving advancements in pharmaceutical science.

🏅Awards: 

Dr. Hongjian Qin has received numerous accolades for his contributions to sustainable chemistry. He was honored as an Excellent Graduate in 2024 by the University of Chinese Academy of Sciences for his outstanding academic achievements during his Ph.D. studies. His work on sustainable pharmaceutical synthesis earned him recognition at various national and international conferences. Dr. Hongjian Qin has been instrumental in developing innovative processes for drug substances, garnering appreciation from industrial partners. Additionally, his mentorship roles and administrative contributions at research institutions have been commended, underscoring his commitment to advancing science and education.

🔬Research Focus:

Dr. Hongjian Qin’s research focuses on sustainable and green chemistry, particularly in the process development of drug substances. He has worked extensively on optimizing synthesis methods for pharmaceutical intermediates, reducing waste, and improving efficiency in drug manufacturing. His innovative approaches emphasize the use of eco-friendly reagents and catalysts, aligning with global sustainability goals. His recent work includes developing ligand-free copper-catalyzed cyclization methods, novel iron-catalyzed cross-coupling reactions, and efficient large-scale processes for active pharmaceutical ingredients (APIs). Dr. Hongjian Qin is dedicated to advancing environmentally responsible techniques in pharmaceutical synthesis, ensuring both industrial viability and ecological preservation.

Publication Top Notes:

1. Direct Esterification of Amides by the Dimethylsulfate-Mediated Activation of Amide C–N Bonds

Authors: Qin, H.; Han, Z.; Bonku, E.M.; Shen, J.; Aisa, H.A.

Year: 2024

Citations: 0

2. An Alternative Approach to Synthesize Sildenafil via Improved Copper-Catalyzed Cyclization

Authors: Odilov, A.; Gong, X.; Qin, H.; Yang, F.; Shen, J.

Year: 2024

Citations: 0

3. Impurity Study of Tecovirimat (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Wang, X.; Shen, J.

Year: 2024

Citations: 1

4. Improved and Ligand-Free Copper-Catalyzed Cyclization for an Efficient Synthesis of Benzimidazoles from o-Bromoarylamine and Nitriles (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Aisa, H.A.; Shen, J.

Year: 2024

Citations: 2

5. Direct Reductive N-Alkylation of Amines with Carboxylic Esters

Authors: Zhang, Y.; Bonku, E.M.; Yang, X.; Shen, J.; Qin, H.

Year: 2024 (In Press)

Citations: 0

6. Iron-Catalyzed Cross-Coupling Reactions of Alkyl Grignard Reagents with Alkenyl Carbonate

Authors: Qin, H.; Yang, X.; Mintah Bonku, E.; Shen, J.; Akber Aisa, H.

Year: 2024 (In Press)

Citations: 0

7. A Review of the Synthetic Strategies Toward the Antiviral Drug Tecovirimat (Review Article)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Zhu, F.; Shen, J.

Year: 2024 (In Press)

Citations: 0

8. An Improved Iodine-Catalyzed Aromatization Reaction and Its Application in the Synthesis of a Key Intermediate of Cannabidiol

Authors: Abduahadi, S.; Bonku, E.M.; Qin, H.; Aisa, H.A.; Shen, J.

Year: 2024 (In Press)

Citations: 0

9. Optimized Synthesis of the Key Intermediate of Telmisartan via the Cyclization of 2-Bromoarylamine with n-Butyronitrile

Authors: Qin, H.; Mintah Bonku, E.; Odilov, A.; Zhu, F.; Aisa, H.A.

Year: 2023

Citations: 1

10. Efficient Large-Scale Process for Tecovirimat via Reactive Distillation for the Preparation of Cycloheptatriene

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Guma, S.D.; Shen, J.

Year: 2023

Citations: 4